https://www.selleckchem.com/pr....oducts/Methazolaston
05 for all). Women were more likely to undergo repeat OHT than men (hazard ratio, 2.93; 95% confidence interval, 1.48-5.81; P.01). After covariate adjustment, female **** and younger age were independently associated with repeat OHT for CAV (P.05). No differences in the primary outcome as well as the individual outcomes of death, MI, or TVR were noted between **** groups in patients who underwent PCI for CAV. Female patients were more likely to undergo redo OHT for CAV. Younger age at time of initial OHT was associated with